Berger, K. L., Triki, I., Cartier, M., Marquis, M., Massariol, M., Böcher, W. O., . . . Kukolj, G. (2014). Baseline Hepatitis C Virus (HCV) NS3 Polymorphisms and Their Impact on Treatment Response in Clinical Studies of the HCV NS3 Protease Inhibitor Faldaprevir. American Society for Microbiology.
Citación estilo ChicagoBerger, Kristi L., et al. Baseline Hepatitis C Virus (HCV) NS3 Polymorphisms and Their Impact On Treatment Response in Clinical Studies of the HCV NS3 Protease Inhibitor Faldaprevir. American Society for Microbiology, 2014.
Cita MLABerger, Kristi L., et al. Baseline Hepatitis C Virus (HCV) NS3 Polymorphisms and Their Impact On Treatment Response in Clinical Studies of the HCV NS3 Protease Inhibitor Faldaprevir. American Society for Microbiology, 2014.